Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Glenmark Pharmaceuticals (GNP IN)
Watchlist
138
Analysis
Health Care
•
India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Glenmark Pharmaceuticals
•
18 Feb 2019 00:00
Glenmark - Earnings Flash - Q3 FY 2018-19 Results - Lucror Analytics
Glenmark’s Q3/18-19 results very much surprised on the upside, with strong revenue and earnings growth after a few weak quarters. This was thanks...
Lucror Analytics
Follow
61 Views
Share
bullish
•
361 Degrees International
•
04 Feb 2019 00:00
Asia HY Monthly - Agency Ratings For Asian Issuers - Lucror Analytics
In this month’s “In-Focus” section, we look at agency ratings for Asian issuers. The Asia Monthly focuses on providing updates on recent events,...
Lucror Analytics
Follow
76 Views
Share
bullish
•
361 Degrees International
•
25 Jan 2019 00:00
Asia HY Trade Recommendations - January 2019 - Lucror Analytics
The Asia HY Trade Recommendations report for January includes a summary of our recommendations, as well as our high-conviction ideas. We also...
Lucror Analytics
Follow
47 Views
Share
bearish
•
Aurobindo Pharma
•
01 Jan 2019 22:29
India Generic Drugs: Antitrust Suit Could Cost Billions
This Insight builds on our previous Insight, India Generic Drugs: US Antitrust Inquiry Widens by discussing estimated potential liabilities and...
Kemp Dolliver, CFA
785 Views
Share
bearish
•
MSCI World Index
•
15 Nov 2018 21:39
Global Markets Outlook: Maintain Defensive Posture
Our outlook for global equity markets remains cautious and we expect additional weakness and consolidation, notwithstanding shorter-term...
Vermilion Research
Follow
545 Views
Share
First
Previous
22
23
24
25
26
27
28
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.0
x